Skip to main content Skip to search Skip to main navigation

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

Product Information

Your knowledge portal for GDP-compliant pharmaceutical logistics. 

It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain!

The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.

One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.

You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP).

  • Where does GDP begin, where does GMP end? What does GDP-compliant mean?
  • When do I also have to take GMP requirements into account?
  • What permits do I need for certain activities?
  • What requirements do I have to fulfil?
  • What is the current legal basis?
  • How am I covered?
  • What authorizations do I have for my work, e.g. from my employer?
  • Who is responsible — the client or the contractor?
  • And many more

What is the difference to the GMP Compliance Adviser?

GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients.
The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance.

In addition, sample documents are available to help you make immediate progress.

Author

Simone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

Available Subscription Plans: Named User Licence (3-month-subscription), Named User Licence (12-month-subscription), Business Package with 5 Named User Licences (12-month-subscription)

With the GMP:KnowHow Pharma Logistics (GDP), you 

  • have access to all relevant information 24/7. 
  • are always up to date thanks to continuous updating. 
  • download practical, editable templates, including SOPs, job descriptions, Quality Agreements (QAs), and more.
  • save a lot of time searching for applicable regulations. 
  • understand even complex topics through practical examples and infographics.

What you need to use our portals: Technical requirements

Contents of the GMP:KnowHow Pharma Logistics (GDP)

  • In the “Practical Knowledge” section, each GDP chapter is explained and interpreted in a clear and practical way.
  • In the “Regulations” tab, you will find all relevant passages from the various pieces of legislation that have been assigned to the respective GDP chapter. This provides a direct overview of the regulatory requirements relevant to each topic.
  • Quality Agreement for GMP/GDP-compliant Logistics Services 
  • Quality Manual 
  • Standard Operating Procedures (SOPs)
  • Job Descriptions 
  • GDP Questionnaire 
  • Site Master File including Organisational Chart 
  • Best practice – the Peither Logistik GmbH

Updates

GMP:KnowHow Pharma Logistics (GDP) is continuously updated to ensure access to the latest information and practical guidance.

All updates are included for the duration of the subscription.

Newsletter Service: You will automatically receive email notifications about important updates and changes through our GMP Insider newsletter.

Target Group

Professionals involved in the storage and transportation of pharmaceutical products:

  • Logistics companies
  • Logistics and quality departments in pharmaceutical companies
  • Wholesalers

GMP:KnowHow Pharma Logistics (GDP) focuses on content that is essential for pharmaceutical logistics service providers and their clients involved in the handling of medicinal products, active pharmaceutical ingredients (APIs), and medical devices.

Do You Have Questions?

Yannic Matt, Kundenbetreuung und IT-Support beim GMP-Verlag

Talk to our customer advisors

Do you have any questions about our products and services? We are here to help.

Customer Reviews

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

You may Also be Interested in the Following Products

Skip product gallery

Recommendations

GMP:KnowHow Pharma Logistics (GDP) | Free Demo Access

GMP:KnowHow Pharma Logistics (GDP) | Free Demo Access

You will receive your login credentials via email. Throughout the week, you will receive further information about the GMP:KnowHow Pharma Logistics (GDP) directly in your inbox. Customer support is available to assist you at any time. You can also direct questions about the content to the editorial team and receive personalized responses. You do not need to cancel your demo access. The free access will end automatically. Advantages at a glance

delivery immediately after receipt of payment
€0.00 net excl. VAT
GMP Compliance Adviser | Corporate Licence | 12M

GMP Compliance Adviser | Corporate Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€3,567.00 net excl. VAT

Recommended Articles

News: Europe

EDQM: New working party on 3D-printed medicinal products

The European Pharmacopoeia Commission (EPC) approved the creation of a working party on 3D-printed medicinal products. Its aim is to support the development of appropriate quality standards in the European Pharmacopoeia (Ph. Eur.).
Read more
EMA: 14 New Nitrosamines for Appendix 1

EMA: 14 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.
Read more
WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO published a revised draft of its “WHO guidelines on quality risk management”. Working document QAS/26.994 is open for public comment until 15 November 2026.
Read more
News: Artificial Intelligence

Annex 22: Results of the EMA Workshop

On 30 June, the EMA’s Annex 22 Working Group discussed the future scope of the annex with AI experts and representatives of the pharmaceutical industry (as previously reported).
Read more
News: Artificial Intelligence

EMA Workshop Regarding Annex 22 "Artifical Intelligence"

The current draft of Annex 22, "Artificial Intelligence", proposes excluding generative AI and large language models (LLMs), as well as probabilistic, dynamic and adaptive AI models, from critical GMP applications. Numerous comments submitted during the public consultation challenged this approach. Instead, the aim should be to support innovation and encourage investment by the pharmaceutical industry.
Read more
Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
News: EMA

EMA: Report on First Bilateral Meeting with APIC Published

The EMA has published the highlights of its first bilateral meeting with the Active Pharmaceutical Ingredients Committee (APIC). Topics included GMP oversight of API manufacturers, the reuse of recovered solvents and nitrosamine risks.
Read more
Previous
Next